Group 02 Paracetamol + Morphine + Ketamine: Clinical Trials

1 trial of Group 02 Paracetamol + Morphine + Ketamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow this drug Literature Review of Group 02 Paracetamol + Morphine + Ketamine trials Research Report on Group 02 Paracetamol + Morphine + Ketamine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adaptive Platform Trial for Pain Management in Sickle Cell Vaso-Occlusive Crisis
Group 02 Paracetamol + Morphine + Ketamine, Group 01 Control: Paracetamol + Morphine, Group 03 : Paracetamol + Morphine + Nefopam - Sickle Cell Disease, Vaso-occlusive Crisis
Phase 4Not yet recruitingAssistance Publique - Hôpitaux de Paris4002026-10-012026-09-18

Conditions studied

Agnosia (1)  ·  Anemia, Sickle Cell (1)  ·  Vaso-Occlusive Crises (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)